TRDA
Entrada Therapeutics, Inc. · Healthcare
President and CEO Dipal Doshi sold $38K of Entrada Therapeutics, Inc.
Sold$37,675
$18.01Price
2,092Shares
−1%Stake
What TRDA did after the filing
- The stock from Thu, Apr 20 open, $15.01
- −18.7%
- S&P 500, same days
- +4.1%
Measured over 30 trading days, to the Jun 2 close.
Traded Mon, Apr 17. Filed Wed, Apr 19. Returns use the Apr 20 open and the Jun 2 close. Not investment advice.